Your search returned 18 results.

Results
	1.	Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based dosimetry for 131I therapy of metastatic differentiated thyroid cancer. MedStar authors: Atkins, Francis Garcia, Carlos Van Nostrand, Douglas PMID: 28104741 Year: 2017 Citation: Journal of Nuclear Medicine. 58(7):1146-1154, 2017 Jul Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Atkins F, Garcia C, Hobbs RF, Huang K, Plyku D, Sgouros G, Van Nostrand D DOI: https://dx.doi.org/10.2967/jnumed.116.179366 Add to cart (remove)
	2.	124I-PET/CT based tumor dosimetry for 131I therapy of metastatic differentiated thyroid cancer (DTC) - a comparison of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal patient preparation methods MedStar authors: Atkins, Francis Garcia, Carlos Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun 6 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Plyku D, Hobbs RF, Huang K, Atkins F, Garcia CA, Sgouros G, Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	3.	124I-PET/CT based tumor dosimetry for 131I therapy of metastatic differentiated thyroid cancer (DTC) - a comparison of recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal patient preparation methods MedStar authors: Atkins, Francis Garcia, Carlos Van Nostrand, Douglas Year: 2015 Citation: Unpublished 2015 Jun Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Plyku D, Hobbs RF, Huang K, Atkins F, Garcia CA, Sgouros G, Van Nostrand D Local accession number: 2015_1 Add to cart (remove)
	4.	I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response. MedStar authors: Garcia, Carlos Plyku, Donika Van Nostrand, Douglas Wu, Di PMID: 35119623 Year: 2022 Citation: Annals of Nuclear Medicine. 36(3):213-223, 2022 Mar. Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Garcia C, Hobbs RF, Plyku D, Sgouros G, Van Nostrand D, Wu D DOI: https://dx.doi.org/10.1007/s12149-021-01655-y Add to cart (remove)
	5.	The utility of 18F sodium fluoride PET bone scans in patients suspected of metastatic skeletal disease secondary to differentiated thyroid cancer MedStar authors: Bethancourt, E Burman, Kenneth D Garcia, Carlos Van Nostrand, Douglas Wartofsky, Leonard Wexler, Jason Year: 2015 Citation: Unpublished 2015 Jun Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Garcia CA, Van Nostrand D, Wexler JA, Bethancourt E, Burman k, Wartofsky l Local accession number: 2015_192 Add to cart (remove)
	6.	Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for metastatic differentiated thyroid cancer (DTC) MedStar authors: Atkins, Frank Garcia, Carlos Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Washington Cancer Institute Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D Local accession number: 2013_4 Add to cart (remove)
	7.	Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for Metastatic Differentiated Thyroid Cancer (DTC). MedStar authors: Atkins, Frank Garcia, Carlos Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Khorjekar G, Orquiza MD, Atkins F, Mete M, Garcia C, Wartofsky L, Van Nostrand D Local accession number: 2013_2 Add to cart (remove)
	8.	Correlation of 124 I PET dosimetry with clinical response of 131 I therapy for metastatic differentiated thyroid cancer. MedStar authors: Atkins, Frank Garcia, Carlos Khorjekar, Gauri Mete, Mihriye Orquiza, Michael D Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D Local accession number: 2013_16 Add to cart (remove)
	9.	The spectrum of 124I uptake in the lacrimal gland and nasolacrimal sac/duct on PET/CT imaging. MedStar authors: Burman, Kenneth D Garcia, Carlos Kulkarni, Kanchan Plyku, Donika Van Nostrand, Douglas Wartofsky, Leonard Wu, Di PMID: 33323865 Year: 2021 Citation: Nuclear Medicine Communications. 42(3):292-299, 2021 Mar 01. Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Burman KD, Garcia C, Kulkarni K, Plyku D, Van Nostrand D, Wartofsky L, Wu D DOI: https://dx.doi.org/10.1097/MNM.0000000000001330 Add to cart (remove)
	10.	Optimal time for 124I PET/CT imaging in metastatic differentiated thyroid cancer. MedStar authors: Burman, Kenneth D Garcia, Carlos A Kulkarni, Kanchan P Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2018 Institution: MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Burman K Garcia C Kulkarni K Van Nostrand D. Wartofsky L Wu D Local accession number: B2018645 Add to cart (remove)
	11.	Optimal time for 124I PET/CT imaging in metastatic differentiated thyroid cancer. MedStar authors: Burman, Kenneth D Garcia, Carlos A Kulkarni, Kanchan P Van Nostrand, Douglas Wartofsky, Leonard Wu, Di Year: 2018 Citation: 2018/04/30/ Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Kulkarni K Burman K Garcia C Van Nostrand D. Wartofsky L Wu D Local accession number: B201889 Add to cart (remove)
	12.	Retrospective study of the utility of 18F sodium fluoride PET bone scans in patients with differentiated thyroid cancer with suspected bone metastases MedStar authors: Burman, Kenneth D Garcia, Carlos O'Neil, Jeffrey Orquiza, Michael D Schneider, Mark Van Nostrand, Douglas Wartofsky, Leonard Wexler, Jason Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Schneider M, Garcia C, O'Neil J, Van Nostrand D, Wexler J, Burman K, Wartofsky L Local accession number: 2013_8 Add to cart (remove)
	13.	Retrospective study of the utility of 18F sodium fluoride PET bone scans in patients with thyroid cancer with suspected bone metastases. MedStar authors: Burman, Kenneth D Garcia, Carlos O'Neil, Jeffrey Orquiza, Michael D Schneider, Mark Van Nostrand, Douglas Wartofsky, Leonard Wexler, Jason Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Schneider M, Garcia C, O'Neil J, Van Nostrand D, Wexler J, Burman K, Wartofsky L Local accession number: 2013_2 Add to cart (remove)
	14.	Optimal Time for 124I PET/CT Imaging in Metastatic Differentiated Thyroid Cancer. MedStar authors: Atkins, Francis Burman, Kenneth D Garcia, Carlos Kulkarni, Kanchan Plyku, Donika Tefera, Eshetu Van Nostrand, Douglas Wartofsky, Leonard Wu, Di PMID: 33492859 Year: 2021 Citation: Clinical Nuclear Medicine. 2021 Jan 21 Institution: MedStar Health Research Institute MedStar Washington Hospital Center MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Form of publication: Journal Article All authors: Atkins F, Burman KD, Garcia C, Kulkarni K, Plyku D, Tefera E, Van Nostrand D, Wartofsky L, Wu D DOI: https://dx.doi.org/10.1097/RLU.0000000000003505 Add to cart (remove)
	15.	Epiphora and xerophthalmia after 131I therapy: the frequency, time of onset, severity, and duration. MedStar authors: Acio, Elmo Burman, Kenneth D Garcia, Carlos Khorjekar, Gauri R Kulkarni, Kanchan Orquiza, Michael H Schneider, M Van Nostrand, Douglas Wartofsky, Leonard Year: 2014 Citation: Unknown 2014 Jun 7 Department: Medicine/Endocrinology Medicine/General Internal Medicine Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D Local accession number: 2014.1_133 Add to cart (remove)
	16.	Characterization of sialoadenitis (SA) after administration of continuous sialogogues (SGs) during the day and night after 131I therapy (tx) MedStar authors: Acio, Elmo Burman, Kenneth D Garcia, Carlos Khorjekar, Gauri Kulkarni, Kanchan Orquiza, Michael D Schneider, Mark Van Nostrand, Douglas Wartofsky, Leonard Year: 2013 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Form of publication: Conference All authors: Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L, Van Nostrand D Local accession number: 2013_7 Add to cart (remove)
	17.	Altered taste after 131I therapy: the frequency, time of onset, severity, and duration MedStar authors: Acio, Elmo Burman, Kenneth D Garcia, Carlos Khorjekar, Gauri R Kulkarni, Kanchan Orquiza, Michael H Schneider, M Van Nostrand, Douglas Wartofsky, Leonard Year: 2014 Citation: Unknown 2014 Jun 7 Department: Medicine/Endocrinology Medicine/General Internal Medicine Medicine/Nuclear Medicine Form of publication: Poster Presentation All authors: Orquiza M, Khorjekar G, Schneider M, Kulkarni K, Garcia C, Acio E, Burman K, Wartofsky L,Van Nostrand D Local accession number: 2014.1_134 Add to cart (remove)
	18.	Do negative 124I pretherapy positron emission tomography scans in patients with elevated serum thyroglobulin levels predict negative 131I posttherapy scans?. MedStar authors: Atkins, Francis Burman, Kenneth Garcia, Carlos Khorjekar, Gauri R Mete, Mihriye Moreau, Shari O'Neil, Jeff Orquiza, Michael H Van Nostrand, Douglas Wartofsky, Leonard PMID: 24820222 Citation: Thyroid. 24(9):1394-9, 2014 Sep. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medicine/Nuclear Medicine Medline publication type: Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Atkins FB, Burman K, Garcia C, Khorjekar GR, Mete M, Moreau S, O'Neil J, Orquiza MH, Van Nostrand D, Wartofsky L DOI: http://dx.doi.org/10.1089/thy.2013.0713 Add to cart (remove)

Powered by Koha